A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer

NCT02291055 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer
Cancer
Head and Neck Cancer

Interventions

DRUG: ADXS11-001
DRUG: MEDI4736

Sponsor

Advaxis, Inc.

Collaborators

[object Object]